Bids Are Invited For Price Registration For The Acquisition Of Digestive Medicines And Metabolites, Aiming To Meet The Demands Of Ipesude Units.

Bisacodil - Concentration/Dosage 5 Mg, Compressed Pharmaceutical Form Or Drague, Oral Administration Via, Dimenhydrinate Glucose Fructose - Concentration/Dosage 3 Mg/Ml 100 Mg/Ml 100 Mg/Ml Respectively, Pharmaceutical Form Injectable Solution, Amplane Presentation, Intravenous Administration. Scopolamine, Butylbrometo - Concentration/Dosage 20 Mg/Ml, Parenteral Administration Via Manner, Dipirone Sodica Butylbromide - Concentration/Dosage 4Mg/Ml 500 Mg/Ml Respectively, 5Ml Ampoule Form, The Packaging Should Bring Externally The Data Identification, Batch Number, Manufacturing Date And Expiration Date. Delivery Date, The Product Should Have At Least 75 Of The Total Validity Period. According To Ordinance 2814 Gm/1998, The Product Must Present In Its Primary And/Or Secondary, Glibenclamide - Concentration/Dosage 5 Mg, Compressed Pharmaceutical Form, Viade Oral Administration, 01/09/2025, Sodium Chloride Glucose - Salts For Oral Rehydration (Sodium Chloride 2, 6G Anide 13, 5G Potassium 1, 5G Dydrated Sodium Citrate 2, 9G) Powder, Envelope Powder For Oral Solution, Envelope, Magnesium Hydroxide Hydroxide - Concentration/Dosage Aluminum Hydroxide 37 Mg/Ml Magnesium Hydroxide 40 Mg/Ml 5 Mg/Ml, Shape Form Oral, Shape Bottle, Lactulose - In Oral Solution With 667Mg/Ml, Pharmaceutical Form Syrup, 120 Ml Vial Form, Metformin, Hydrochloride - Concentration/Dosage 850 Mg, Pharmaceutical Form Coated Compressed, Chloride - Concentration/Dosage 500 Mg, Metoclopramide, Hydrochloride - Hydrochloride - Concentration/Dosage 5Mg/Ml, Injectable Solution, 2Ml, Intramuscular And Intravenous Ampoule, Saccharomyces Boulardii 17 - Concentration/Dosage 200 Mg/G, Oral Pharmaceutical Form, Form Of Introduction Envelope, Simeticona - Concentration/Dosage 75 Mg/Ml, Complex B - Composition Thiamine Riboflavin Nicotinamidapantoslpiridoxine Cyanocobalamin, Pharmaceutical Form Injectable Solution, 2Ml Ampoule, Intramuscular Or Intravenous Administration, Ascorbic Acid - Concentration/Dosage 100 Mg/Ml, Pharmaceutical Form Of Conjective Solution, Form Of 5 Ml Ampoule, Via Administration Intravenous, Bromopred - Concentration/Dosage 5 Mg/Ml, Pharmaceutical Form Injectable Solution, 2Ml Ampoule Form, Intravenous Or Intramuscular Administration, Human Insulin - Nph Type, Concentration/Dosage 100 Iu/Ml, Injectable Pharmaceutical Form, Form Of 10Ml Ampoule Display, The Packaging Should Bring External To External Identification Data, Date Of Manufacture And Expiration Date. In The Date Of Delivery, The Product Must Present In Its Primary And/Or Secondary Packaging, Human Insulin - Regular Type, Wavenstrone, Hydrochloride - Concentration/Dosage 2 Mg, Form Of Presentation Ampoule With 2Ml, Intravenous And Intramuscular Administration, Pyridoxine Dimensicin - Concentration/Dosage 50 Mg/Ml/Ml Mg/Ml, Formopharmaceutical Injectable Solution, Intramuscular Administration, Sodium Bicarbonate - Pharmaceutical Form Injectable Solution, Concentration/Dosage 8, 4, 10Ml Ampoule Form, Potassium Chloride - In An Injectable Solution At 19, 1, In Ampoule With 10 Ml, The Product Should Have Sodium Chloride - Sodium Chloride Injectable Solution At 20 In Ampoule With 10 Ml, Packed As Stated In The Registration Of The Product